Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/1996
09/18/1996EP0531370B1 Inhibition of viral infection
09/18/1996CN1131438A Protein having TPO activity
09/18/1996CN1131424A Androstenone derivative
09/18/1996CN1131392A Nitric oxide donor composition and method for treatment of anal disorders
09/18/1996CN1131391A Use of thiazolidinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
09/18/1996CN1131389A Use of oligosaccharides for prevention and treatment of tissue ageing
09/18/1996CN1131155A New tricyclic oxime ethers, processes for their preparation and pharmaceutical compositions containing them
09/18/1996CN1131150A 3-phenyl isoquinolin-1(2H)-one derivant, its preparation method and medicinal use thereof
09/18/1996CN1131144A Glycinamide derivatives, processes for their preparation and medicines containing them
09/18/1996CN1131041A Soft gelatin pharmaceutical dosage form
09/18/1996CN1131033A Traditional Chinese medicine oral liquor for narcotics abstinence
09/18/1996CN1131028A Nutritious health-care oral liquor
09/18/1996CN1032815C Method for preparation of selective adenosine receptor agents
09/17/1996US5556990 Squalene synthase inhibitors, anticholesterol agents
09/17/1996US5556981 Angiotensin II antagonist intermediates
09/17/1996US5556942 Glutathione S-transferase-activated compounds
09/17/1996US5556909 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
09/17/1996US5556870 Use of leflunomide for inhibiting interleukin 1 beta
09/17/1996US5556866 Hair restorer and its preparation
09/17/1996US5556862 Pharmaceutical compositions containing isoquinoline derivatives
09/17/1996US5556856 Anitarrhythmia, analgesics
09/17/1996US5556854 Cardiovascular disorders and/or neurogenerative disorders
09/17/1996US5556845 11-β substituted-19-nor steroids
09/17/1996US5556844 Synergistic, skin disorders
09/17/1996US5556843 Treatment of central nervous system disorders, inhibits activation of protein kinase c
09/17/1996US5556838 Blocking n-methylaspartate receptors to prevent addiction
09/17/1996US5556785 Lactobacillus used to enhance immunological functions
09/17/1996US5556763 Patterns of transcription factors and lymphocytes
09/17/1996US5556754 Major histocompatibility complex, treatment of autoimmune diseases
09/17/1996US5556753 DNA encoding human α1 adrenegric receptors and uses thereof
09/17/1996CA2004249C Arylpiperidine derivatives
09/14/1996CA2171579A1 Piperidine derivatives, process for the preparation thereof and application thereof in therapeutics
09/12/1996WO1996027601A1 Phosphorylated nitrone derivatives, method for preparing same, and compositions containing said derivatives
09/12/1996WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity
09/12/1996WO1996027588A1 Indole derivatives as eaa antagonists
09/12/1996WO1996027583A1 Arylsulfonylamino hydroxamic acid derivatives
09/12/1996WO1996027390A1 Compositions and methods for stimulating antibody class switching
09/12/1996WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
09/12/1996WO1996027384A2 Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase
09/12/1996WO1996027374A1 Treatment of cytokine growth factor caused disorders
09/12/1996WO1996021468A3 Chemically modified interferon
09/12/1996WO1996020718A3 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
09/12/1996CA2214726A1 Compositions and methods for stimulating antibody class switching
09/12/1996CA2214583A1 Indole derivatives as eaa antagonists
09/11/1996EP0731109A1 Purification of D-factor
09/11/1996EP0731101A1 3-Benzyl-benzothiophenes
09/11/1996EP0731098A1 Alpha-substituted-3-benzyl-benzofurans
09/11/1996EP0731093A1 Naphthyl pharmaceutical compounds
09/11/1996EP0730865A1 Use of serotonin and dopamine receptor blockers for the treatment of mental disorders associated with cerebrovascular disease
09/11/1996EP0730861A1 Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
09/11/1996EP0730661A1 Compounds with pth activity and recombinant dna vectors encoding same
09/11/1996EP0730657A1 Composition for the in vivo production of therapeutic products
09/11/1996EP0730651A1 Surface loop structural analogues of fibroblast growth factors
09/11/1996EP0730648A1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
09/11/1996EP0730647A1 Dna sequence coding for a bmp receptor
09/11/1996EP0730646A1 PROTEIN TYROSINE KINASES NAMED Rse
09/11/1996EP0730605A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
09/11/1996EP0730594A1 NOVEL 9-HYDROXY-PYRIDO [1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES
09/11/1996EP0730590A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
09/11/1996EP0730587A1 3-aryl-2-isoxazolines as antiinflammatory agents
09/11/1996EP0730579A1 Substituted indoles as phosphodiesterase type iv inhibitors
09/11/1996EP0730578A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
09/11/1996EP0730571A1 Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors
09/11/1996EP0730470A1 Improved interferon polymer conjugates
09/11/1996EP0730469A1 Modified truncated complement system regulators
09/11/1996EP0730465A1 Use of angiotensin iii and analogs thereof in tissue repair
09/11/1996EP0730460A1 The use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions
09/11/1996EP0730451A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
09/11/1996EP0730448A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
09/11/1996EP0591392B1 Pharmaceutical formulations of osteogenic proteins
09/11/1996EP0507861B1 Diaromatic substituted anti-aids compounds
09/11/1996EP0484401B1 Production of vascular endothelial cell growth factor
09/11/1996EP0450066B1 Carbostyril derivatives
09/11/1996EP0372031B1 Biosynthetic osteogenic proteins and osteogenic devices containing them
09/11/1996CN1130909A 5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
09/11/1996CN1130907A Process for preparation of indolizine derivatives
09/11/1996CN1130905A Process for making HIV protease inhibitors
09/11/1996CN1130899A Novel structural analogues of vitamin D
09/11/1996CN1130898A Difluoro statone antiviral analogs
09/11/1996CN1130872A Use of benzydamine in treatment of pathological conditions caused by TNF
09/11/1996CN1130626A Adhesion receptor antagonists
09/11/1996CN1130532A Modulation of cellular activity
09/11/1996CN1032750C Process for prepn. of ureido derivatives of poly 4-amino-2-carboxy-1-methyl compounds
09/11/1996CA2171404A1 3-benzyl-benzothiophenes
09/11/1996CA2171403A1 .alpha. substituted-1-benzyl-naphthyls
09/11/1996CA2171399A1 Substituted-3-benzyl-benzofurans
09/10/1996US5554756 Amino acid derivatives
09/10/1996US5554646 Method for reducing body fat in animals
09/10/1996US5554643 Pro-drugs for CCK antagonists
09/10/1996US5554642 Arylalkyl(thio) amides
09/10/1996US5554638 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
09/10/1996US5554637 Use of leflunomide for inhibiting interleukin 1 alpha
09/10/1996US5554634 N-(hydroxyethyl)butanediamide derivatives
09/10/1996US5554629 Headaches
09/10/1996US5554624 Imidazopyridine derivatives as angiotensin II antagonists
09/10/1996US5554621 Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
09/10/1996US5554599 22-thio vitamin D derivatives
09/10/1996US5554598 Method of treating crural or decubitus ulcer with zinc hyaluroric acid complex
09/10/1996US5554389 Urinary bladder submucosa derived tissue graft
09/10/1996US5554375 Hair growth
1 ... 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 ... 1564